Company Filing History:
6 out of 7 
2 out of 25 
1 out of 12 Years Active: 2017-2025
Title: Doohwan Jung: Innovator in Antibody-Drug Conjugates
Introduction
Doohwan Jung is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of antibody-drug conjugates. With a total of 8 patents, his work has the potential to impact therapeutic approaches in various medical applications.
Latest Patents
Among his latest patents, Doohwan Jung has developed compounds and compositions comprising substituted benzodiazepines as antibody-drug conjugates. This innovation provides new avenues for targeted therapy. Additionally, he has worked on antibody-drug conjugates that utilize anti-B7-H3 antibodies, which are designed to link active agents to the antibody through a specialized linker. This technology includes monoclonal antibodies and antigen-binding fragments that specifically target B7-H3, offering promising methods for therapeutic, diagnostic, and prophylactic applications.
Career Highlights
Doohwan Jung has been associated with notable companies such as Intocell, Inc. and Legochem Biosciences, Inc. His work in these organizations has allowed him to advance his research and contribute to the development of innovative medical solutions.
Collaborations
Throughout his career, Doohwan Jung has collaborated with talented individuals, including Taekyo Park and Sunyoung Kim. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Doohwan Jung's contributions to the field of antibody-drug conjugates exemplify his innovative spirit and dedication to advancing medical science. His patents and collaborations highlight the importance of teamwork in achieving significant breakthroughs.